![](/img/cover-not-exists.png)
P168 Time-to-failure in 1st-line endocrine therapy with ER+/HER2−metastatic breast cancer
Nishimura, S., Akiyoshi, S., Koga, C., Oikawa, M., Nskamura, Y., Ishida, M., Ohno, S.Volume:
24
Language:
english
Journal:
The Breast
DOI:
10.1016/S0960-9776(15)70209-2
Date:
March, 2015
File:
PDF, 65 KB
english, 2015